Lift twice a week. Keep the muscle you’d otherwise lose.
Two 45-minute sessions a week, heavy compounds, low volume — that is the whole plan, and it matters more on a GLP-1, not less. These drugs drop the scale fast; your job in the gym is to make sure what leaves is fat, not the muscle underneath it.
What’s actually coming off
The weight loss is large and well-documented. In STEP 1 (Wilding et al., NEJM 2021; 1,961 adults with obesity, no diabetes), semaglutide 2.4 mg weekly produced a −14.9% mean body-weight change at week 68 versus −2.4% on placebo. SURMOUNT-1 (Jastreboff et al., NEJM 2022; 2,539 adults) went further with tirzepatide: −15.0%, −19.5%, and −20.9% at 5, 10, and 15 mg over 72 weeks, versus −3.1% placebo.
Here is the caveat the marketing skips. DXA substudies of GLP-1 trials show a meaningful fraction of the lost weight is lean mass, not fat. That is a real signal on incomplete data, not a settled number: resistance training plus adequate protein is the standard countermeasure, but we do not yet have good long-term data on the functional consequences of that lean-mass loss. Treat the training as insurance against an outcome nobody has characterized well.
The plan
Two days. Heavy, low volume. You are signaling “keep this tissue,” not chasing a PR.
Day A — push + legs
- Squat or leg press: 3×5–8
- Bench or dumbbell press: 3×6–10
- Dumbbell shoulder press: 3×8–12
- Triceps pushdown: 2×12–15
Day B — pull + legs
- Deadlift or trap-bar lift: 3×4–6
- Pull-up or lat pulldown: 3×6–10
- Dumbbell row: 3×8–12
- Biceps curl: 2×12–15
Feed the muscle: protein first
Clinicians commonly target 1.2–1.6 g of protein per kg of body weight per day during a GLP-1 deficit — higher than general intake, because appetite suppression makes under-eating protein the default failure mode. Hit that target every day. The training stimulus does nothing if there is no substrate to rebuild with.
Training around the nausea
Nausea is the most common side effect of semaglutide, and it is not random — it follows from the mechanism. GLP-1 receptor agonists slow gastric emptying and act on appetite circuits in the hypothalamus and hindbrain; the delayed emptying is what makes you queasy. In STEP 1 the nausea clustered during dose escalation and eased as titration slowed. Standard titration starts at 0.25 mg weekly and steps up roughly every four weeks (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), slower if side effects bite. At Zappy a US-licensed clinician reviews every case and sets that pace; if the nausea is winning, the right move is a slower step, not a skipped week.
Practical translation: train in the morning, before the day’s nausea peaks. Protein within about 30 minutes after. Hydrate hard, especially in the first month. If a session feels off, do half and leave — grinding through buys you nothing.
Cardio is a supporting actor
Don’t trade lifting for cardio when the goal is body composition. Walk 8–10k steps a day on top of the two sessions. Cardio is for your heart, mood, and recovery — the resistance work is what defends the muscle.
What to track
One number: the top-set weight of each lift, weekly. Flat or rising during a deficit means you are holding muscle — you are winning. Dropping fast usually means too little protein, too little sleep, or too little food, in that order.
The part people learn the hard way
The muscle you protect now is muscle you don’t have to rebuild later — and “later” arrives for most people. STEP 4 (Rubino et al., JAMA 2021) stopped semaglutide at week 20 and saw substantial regain versus continuing. SURMOUNT-4 (Aronne et al., JAMA 2024) switched people off tirzepatide after 36 weeks: they regained about 14% of body weight over the next year, while those who stayed on lost about 5.5% more. Weight loss on these drugs is maintained by staying on them. If regain does come, the muscle you kept is a head start you can’t buy back quickly.
The open question is not whether the drugs work — SELECT (Lincoff et al., NEJM 2023) showed semaglutide cut major adverse cardiovascular events by 20% relative (HR 0.80) in 17,604 adults with cardiovascular disease and no diabetes. It is how much the lean-mass loss matters over a decade, and whether training fully offsets it. Nobody has run that trial. Until someone does: lift twice a week, and eat your protein.
